MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
New England Journal of Medicine
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

1,573 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
1,573 works in the cohort · of 4,299,418page 1 of 32

Labels cover 19 of 1,573 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 1,573 of 1,573 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affunlabeled
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf, John W. Eikelboom, Jonas Oldgren, Amit Parekh +14 more
2009· article· en· New England Journal of Medicine· Medicine
machine prediction:candidate · noneconsensus · none
11,200
citations
affunlabeled
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Paul M. Ridker, Tom Thurén, Jean MacFadyen, William H. Chang, Christie M. Ballantyne, Francisco Antônio Helfenstein Fonseca +21 more
2017· article· en· New England Journal of Medicine· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
9,109
citations
affunlabeled
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger, John H. Alexander, John J.V. McMurray, Renato D. Lópes, Elaine M. Hylek, Michael G. Hanna +26 more
2011· article· en· New England Journal of Medicine· Medicine
machine prediction:candidate · noneconsensus · none
8,914
citations
affunlabeled
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman, Axel Hauschild, Caroline Robert, John B.A.G. Haanen, Paolo A. Ascierto, James Larkin +22 more
2011· article· en· New England Journal of Medicine· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
7,688
citations
affunlabeled
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso, Gilbert H. Daniels, Kirstine Brown‐Frandsen, Peter Lommer Kristensen, Johannes F.E. Mann, Michael A. Nauck +9 more
2016· article· en· New England Journal of Medicine· Medicine
machine prediction:candidate · noneconsensus · none
7,350
citations
affunlabeled
Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
Edward B. Garon, Naiyer A. Rizvi, Rina Hui, Natasha B. Leighl, Ani Sarkis Balmanoukian, Joseph P. Eder +21 more
2015· article· en· New England Journal of Medicine· Medicine
machine prediction:candidate · noneconsensus · none
6,228
citations
affunlabeled
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
Robert J. Motzer, Bernard Escudier, Ray McDermott, Saby George, Hans J. Hammers, Sandhya Srinivas +21 more
2015· article· en· New England Journal of Medicine· Medicine
machine prediction:candidate · noneconsensus · none
5,890
citations
affunlabeled
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
Frances A. Shepherd, José Rodrigues Pereira, Tudor–Eliade Ciuleanu, Eng Huat Tan, Vera Hirsh, Sumitra Thongprasert +13 more
2005· article· en· New England Journal of Medicine· Medicine
machine prediction:candidate · noneconsensus · none
5,451
citations
affgemma · no categorygpt · no categorymodels split
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
Caroline Robert, Georgina V. Long, Benjamin Brady, Caroline Dutriaux, Michele Maio, Laurent Mortier +22 more
2014· article· en· New England Journal of Medicine· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
5,352
citations
affunlabeled
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
Robert P. Giugliano, Christian T. Ruff, Eugene Braunwald, Stephen D. Wiviott, Jonathan L. Halperin, Albert L. Waldo +14 more
2013· article· en· New England Journal of Medicine· Medicine
machine prediction:candidate · noneconsensus · none
5,126
citations

How this was built: Screen · Findings · About